tiprankstipranks
Cassava Sciences’ Q3 2024: Financials and Alzheimer’s Trials Progress
PremiumCompany AnnouncementsCassava Sciences’ Q3 2024: Financials and Alzheimer’s Trials Progress
13d ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
14d ago
Cassava Sciences reports Q3 EPS (58c) vs. (61c) last year
Premium
The Fly
Cassava Sciences reports Q3 EPS (58c) vs. (61c) last year
14d ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
20d ago
Cassava Sciences put volume heavy and directionally bearish
Premium
The Fly
Cassava Sciences put volume heavy and directionally bearish
21d ago
Cassava Sciences call volume above normal and directionally bullish
Premium
The Fly
Cassava Sciences call volume above normal and directionally bullish
29d ago
Cassava Sciences Advances Alzheimer’s Trials Amid SEC Settlement
PremiumCompany AnnouncementsCassava Sciences Advances Alzheimer’s Trials Amid SEC Settlement
1M ago
Cassava Sciences to announce top-line results of ReTHINK trial before year-end
Premium
The Fly
Cassava Sciences to announce top-line results of ReTHINK trial before year-end
1M ago
Cassava Sciences up 8% at $27.44 in pre-market following CEO letter
Premium
The Fly
Cassava Sciences up 8% at $27.44 in pre-market following CEO letter
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100